IQ-AI LTD. LS -01 (5Y1) - Net Assets

Latest as of June 2025: €513.62K EUR ≈ $600.48K USD

Based on the latest financial reports, IQ-AI LTD. LS -01 (5Y1) has net assets worth €513.62K EUR (≈ $600.48K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€988.68K ≈ $1.16 Million USD) and total liabilities (€475.06K ≈ $555.39K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore cash flow conversion of IQ-AI LTD. LS -01 to assess how effectively this company generates cash.

Key Net Assets Metrics

Metric Value
Current Net Assets €513.62K
% of Total Assets 51.95%
Annual Growth Rate -36.66%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 134.39

IQ-AI LTD. LS -01 - Net Assets Trend (2021–2024)

This chart illustrates how IQ-AI LTD. LS -01's net assets have evolved over time, based on quarterly financial data. Also explore IQ-AI LTD. LS -01 assets under control for the complete picture of this company's asset base.

Annual Net Assets for IQ-AI LTD. LS -01 (2021–2024)

The table below shows the annual net assets of IQ-AI LTD. LS -01 from 2021 to 2024. For live valuation and market cap data, see IQ-AI LTD. LS -01 stock valuation.

Year Net Assets Change
2024-12-31 €302.53K
≈ $353.69K
+218.70%
2023-12-31 €94.92K
≈ $110.98K
-86.58%
2022-12-31 €707.07K
≈ $826.64K
-40.62%
2021-12-31 €1.19 Million
≈ $1.39 Million
--

Equity Component Analysis

This analysis shows how different components contribute to IQ-AI LTD. LS -01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 141791300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components €23.39 Million 7730.10%
Total Equity €302.53K 100.00%

IQ-AI LTD. LS -01 Competitors by Market Cap

The table below lists competitors of IQ-AI LTD. LS -01 ranked by their market capitalization.

Company Market Cap
Cadogan Petroleum plc
LSE:CAD
$123.75K
Sumo Resources PLC
PA:MLSUM
$124.00K
PowerHouse Energy Group Plc
LSE:PHE
$125.14K
React Group PLC
LSE:REAT
$126.54K
Marlowe plc
LSE:MRL
$122.94K
Rockfire Resources plc
LSE:ROCK
$122.89K
Arcontech Group Plc
LSE:ARC
$122.84K
MagForce AG
STU:MF6
$122.48K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in IQ-AI LTD. LS -01's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 94,924 to 302,527, a change of 207,603 (218.7%).
  • Net loss of 327,103 reduced equity.
  • New share issuances of 359,890 increased equity.
  • Other factors increased equity by 174,816.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €-327.10K -108.12%
Share Issuances €359.89K +118.96%
Other Changes €174.82K +57.79%
Total Change €- 218.70%

Book Value vs Market Value Analysis

This analysis compares IQ-AI LTD. LS -01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.37x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.08x to 0.37x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-12-31 €0.01 €0.00 x
2022-12-31 €0.00 €0.00 x
2023-12-31 €0.00 €0.00 x
2024-12-31 €0.00 €0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently IQ-AI LTD. LS -01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -108.12%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -43.61%
  • • Asset Turnover: 0.81x
  • • Equity Multiplier: 3.07x
  • Recent ROE (-108.12%) is above the historical average (-219.93%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 -42.08% -96.16% 0.33x 1.33x €-620.13K
2022 -72.35% -95.47% 0.44x 1.70x €-582.31K
2023 -657.17% -102.37% 0.85x 7.59x €-633.31K
2024 -108.12% -43.61% 0.81x 3.07x €-357.36K

Industry Comparison

This section compares IQ-AI LTD. LS -01's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $512,096,409
  • Average return on equity (ROE) among peers: -546.83%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
IQ-AI LTD. LS -01 (5Y1) €513.62K -42.08% 0.92x $123.35K
YIDU TECH INC. DL -00002 (0EL) $4.16 Billion -15.11% 0.18x $673.03 Million
CERTIVE SOLUTIONS INC. (5CE) $-10.47 Million 0.00% 0.00x $253.72K
UPHEALTH INC (5XV) $55.10 Million -104.96% 3.21x $5.44 Million
NIGHTINGALE HEALTH EO 1 (7XE) $97.36 Million -18.57% 0.10x $36.30 Million
TRELLUS HEALTH LS -0006 (85Q) $19.50 Million -32.51% 0.04x $215.06K
SPOTLITE360 IOT SOLUTIONS (87A0) $295.66K -4766.19% 10.32x $916.43K
DocCheck AG (AJ91) $40.08 Million 13.18% 0.52x $78.14 Million
CompuGroup Medical SE & Co. KGaA (COP) $185.83 Million 6.30% 1.43x $1.17 Billion
KNEAT.COM INC. (FOBK) $65.02 Million -3.61% 0.87x $303.17 Million

About IQ-AI LTD. LS -01

F:5Y1 Germany Health Information Services
Market Cap
$144.21K
€123.35K EUR
Market Cap Rank
#31127 Global
#2803 in Germany
Share Price
€0.00
Change (1 day)
+0.00%
52-Week Range
€0.00 - €0.02
All Time High
€0.11
About

Imaging Biometrics Ltd., through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, Switzerland, European Union, and the United States. It operates through Holding Company, Medical Software, and Oral Gallium Maltolate (GaM) segments. The company develops ready-to-use software applications for the healthcare industry compri… Read more